Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians

Eur J Haematol. 1999 Jul;63(1):26-8. doi: 10.1111/j.1600-0609.1999.tb01846.x.

Abstract

The role of hereditary antithrombotic protein defects in juvenile deep vein thrombosis (DVT) was evaluated. Fifty six young patients (age <45 yr) with doppler-proven DVT were investigated for the presence of resistance to activated protein C (APC-R), lupus anticoagulant (LA), anticardiolipin antibodies and deficiencies of protein C, protein S, ATIII activities. Fifty nine normal healthy individuals served as controls. APC-R was observed to be the commonest defect underlying the Indian DVT as seen in 39.2% of patients followed by elevated ACA (5.3%), PAI (2.8%), presence of LA (2.8%) and reduced ATIII levels (2.8%). None of the subjects had protein C or S deficiency. APC-R was associated with ATIII deficiency in one case, and elevated ACA in two cases. In two subjects, APC-R was associated with elevated PAI levels. Patients with more than one prothrombotic factor had a higher prevalence of pulmonary thromboembolism, suggesting that the thrombogenic potential of APC-R is enhanced by the presence of coexisting hereditary or acquired prothrombotic defect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activated Protein C Resistance / complications
  • Activated Protein C Resistance / genetics
  • Adolescent
  • Adult
  • Antibodies, Anticardiolipin / analysis
  • Child
  • Female
  • Humans
  • India / epidemiology
  • Lupus Coagulation Inhibitor / analysis
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / analysis
  • Protein C Deficiency / complications
  • Protein C Deficiency / genetics
  • Protein S Deficiency / complications
  • Protein S Deficiency / genetics
  • Venous Thrombosis / epidemiology
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / genetics

Substances

  • Antibodies, Anticardiolipin
  • Lupus Coagulation Inhibitor
  • Plasminogen Activator Inhibitor 1